{"podcast":{"title":"London News Today | 2 Min News | The Daily News Now!","slug":"london-news-today-2-min-news-the-daily-news-now-7573121","podcast_index_feed_id":7573121,"rss_url":"https://feeds.fastcast.ai/atlanta-dream-the-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/atlanta-dream-the-daily-news-now.jpg","author":"The Daily News Now!","episode_count":1546,"summary":"Voiced by Corey with the Story, stay updated with London's latest local news, weather, community updates, and events. Our 2-minute episodes are designed to keep you informed quickly and efficiently.DNN | The Daily News Now!The world’s first global local news network.Every city. Every story. AI powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-27T08:22:47.144826+00:00","page_url":"https://stenobird.com/podcast/london-news-today-2-min-news-the-daily-news-now-7573121"},"episode":{"title":"Galleri Blood Test Falls Short in Major Trial","slug":"galleri-blood-test-falls-short-in-major-trial","published_at":"2026-05-30T12:25:35+00:00","page_url":"https://stenobird.com/podcast/london-news-today-2-min-news-the-daily-news-now-7573121/galleri-blood-test-falls-short-in-major-trial","show_page_url":"https://stenobird.com/podcast/london-news-today-2-min-news-the-daily-news-now-7573121","url":"https://api.fastcast.ai/audio/2b2fcd2d-ff79-46f8-9dd0-11731511d7f0.mp3","audio_url":"https://api.fastcast.ai/audio/2b2fcd2d-ff79-46f8-9dd0-11731511d7f0.mp3","summary":"A massive UK trial testing the Galleri blood test on 142,000 asymptomatic people failed to meet its main goal of reducing late-stage cancer diagnoses, though it showed promising secondary results—like a 14% drop in stage four cancers. While Grail sees potential, experts urge caution, noting the primary endpoint wasn’t hit and full mortality data won’t be available for years. For now, the test isn’t ready for widespread use—but the glimmers of early detection are still worth watching. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/b64b0bbe018fa6ae","meta_description":"A massive UK trial testing the Galleri blood test on 142,000 asymptomatic people failed to meet its main goal of reducing late-stage cancer diagnoses, tho…","key_points":[],"chapters":[],"topics":[],"duration_seconds":120,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/london-news-today-2-min-news-the-daily-news-now-7573121/episodes/galleri-blood-test-falls-short-in-major-trial/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/london-news-today-2-min-news-the-daily-news-now-7573121/galleri-blood-test-falls-short-in-major-trial.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}